Retroviral vectors are effective shuttle systems by introducobtained and tested for primary transduction rates, rapid ing therapeutically relevant genes stably into the genome detection of transduced cells within 48 h and correction of of proliferating cells. The majority of vectors applied for mitomycin C-induced cell cycle G2 phase accumulation in research or clinical applications use neomycin for cell a single assay using multiparameter, dual laser flow cytoselection and identification. To circumvent the time conmetry. Primary transduction efficiency detected via ͗l-suming and potentially toxic G418 selection process in NGFR͘ antibody was between 5% and 30% with Fanconi transduction studies we constructed a novel marker vector cell lines, 5% with CD34 + cells and 15% with PBLs. MMCusing l-NGFR as a cell surface marker to identify DNA induced G2 phase cell cycle disturbances were fully comprepair defective Fanconi anemia cells complemented with lemented in Fanconi anemia B cell lines of compthe FAC gene. The new vector constructed is based on a lementation group C but not in B cell lines of another FA MoMLV backbone, a signal peptide-deleted l-NGFR recepcomplementation group (D). In addition to the normaliztor gene under control of a LTR promoter and the theraation of the G2 phase arrest, induction of cell death in peutically relevant FAC gene placed downstream of a the FAC cell line was also decreased three-to 10-fold at SV40 promoter. Supernatants containing high titers of different MMC concentrations. amphotropic viruses from FACS cloned cell cultures were
Introduction
patients by gene therapy. 13 However, the retroviral FAC Fanconi anemia (FA) is an autosomal recessive inherited vectors reported up to now and used in the clinical trial disorder characterized by defective DNA repair. 1 Clinicontain xenogenic selection markers like neomycin with cally it is manifested by progressive bone marrow failure, the potential risk of immune response and in vivo congenital abnormalities and predisposition to maligdepletion of the transduced progenitor cells. 14 nancy. 2 Most patients suffer from complications of severe Here we describe the development of a novel FAC vecbone marrow failure and pancytopenia or from the develtor based on a MoMLV backbone using a physiologically opment of acute leukemia or solid tumors. 3 At the celluexisting l-NGFR cell surface marker. 15 This vector avoids lar level the FA phenotype is characterized by a marked time consuming and potentially toxic G418 selection and increase of chromosomal aberrations induced by mitomyallows direct quantification of primary transduction cin C (MMC) or diepoxybutane (DEB). 4 Compared with rates, cell proliferative correction of transduced DNA normal cells, FA cells show a delayed transit through the repair gene deficient cells and cell viability after MMC G2 phase and partial G2 phase arrest of their cell cycle. [5] [6] [7] treatment using flow cytometry. Somatic cell fusion experiments have established the existence of at least five complementation groups (A, B, C, D and E). 8 One gene causing the symptoms of FA has Results so far been identified. This Fanconi anemia complementation group C gene (FAC), has a coding region of Generation of the retroviral l-NGFR/FAC vector 1677 bp. The 558 amino acid FAC protein has a predicted
The FAC/l-NGFR construct shown in Figure 1 is based mass of 63 kDa. 9 The FAC defect is found in about 15% of on a MoMLV retroviral backbone. The l-NGFR gene has all FA patients. In vitro studies reported previously have been truncated to delete the intracellular signalling shown that transfected FAC cDNA corrects the proliferatdomain. 16 This modified marker gene is placed under the ive defects resulting in normal G2 transit in the presence control of the 5′LTR promoter. The l-NGFR receptor of MMC. [10] [11] [12] domain serves as a marker protein on the cell surface of Recently a clinical trial has been initiated to show safe transduced cells. The therapeutically relevant FAC gene administration of FAC-transduced hematopoietic CD34 + is driven by a SV40 promoter.
To achieve optimal transduction efficiencies we transfected E86 cells to produce ecotropic viruses. Best supernatants of FACS cloned E86 cell clones were subsequently used to infect amphotropic retrovirus producing cells. l-about a two log l-NGFR expression relative to the cellular background fluorescence.
Retrovirus-mediated gene transfer and expression of the l-NGFR gene To validate the general usefulness of our FAC/l-NGFR vector we applied ecotropic and amphotropic retroviruses to infect mouse cells (E86, NIH3T3) as well as different permanent cell lines (K562, HSC536, HSC62) and normal diploid cells of human origin (PBLs, CD34 + ). The flow cytometric analyses are shown in Figure 3 .
In the ecotropic E86 and the NIH3T3 cell line the transduction efficiencies were 8.5% and 22%, respectively. The transduction efficiency of the FAC/l-NGFR virus supernatant tested on K562 cells at cell densities of 3 × 10 5 /ml varied between 50% and 70% on K562 cells using single transduction steps (Figures 2 and 3) . The primary transduction rate of different Fanconi B cell lines was consistently lower and ranged between 5% and 30%. In repeat experiments the mean transduction rate of the FAC cell line HSC536 was 25%. The transduced l-NGFR express- addition, conversion of a 15% FAC/l-NGFR-positive FAC cell population to more than 90% has been achieved with a 1 week 1 ng/ml MMC selection. Similar transduc-NGFR-positive cells were cloned by FACS and amphotropic supernatants were tested for transduction tion rates as for FA B cell lines were achieved with human normal diploid lymphocytes. PBLs with only a efficiencies on K562 cells. As shown in Figure 2 the majority of these clones produced sufficient amphotropic single 2 h transduction step showed a primary transduction rate of 15%. viruses for transduction of K562 cells. l-NGFR expression occurred as early as 12 h after transduction and was sigWe also tested the ability of the virus supernatant to infect CD34 + cells obtained from cord blood and bone nificantly above background. A single retroviral supernatant incubation period of 2 h on K562 resulted in transmarrow. CD34 + cells were sorted by flow cytometry, stimulated with a cytokine cocktail for 3 days and incuduction efficiencies between 2% and 87% as analyzed 24 h later by l-NGFR immunofluorescence.
17 Some amphobated in a single 2 h step with viral supernatant. Transduction rates were measured 24 h later by dual ͗l-NGFR͘ tropic producer clones showed clumping morphologies, and only cells growing in adherent monolayers produced and ͗CD34͘ immunostaining using flow cytometry. Transduction rates of viable CD34 + cells obtained from high titer supernatants. Producer clones giving highest transduction efficiencies were expanded and showed cord blood were between 3.5% and 7%, and for CD34 + cells obtained from bone marrow varied between 3.5% stable expression of l-NGFR and stable production of high titer supernatants for more than 20 weeks of conand 4.7%. As is evident from Figure 3 , the l-NGFR expression on single cells as analyzed by flow cytometry tinuous cell culture. For further retroviral transduction experiments of different cell types, supernatant from was about two decades above background independent of the phylogenetic and ontogenetic origin of the cell clone A was used ( Figure 2 ). Independent of the producer clones tested, transduced K562 cells exhibited constantly types tested.
Figure 2 Transduction efficiencies using cell culture supernatants of different FAC/l-NGFR vector producing clones on K562 cells. Flow cytometric l-NGFR analysis was 24 h after transduction. Supernatant from clone A with the highest transduction efficiency was used for further experiments.

Figure 3 Retroviral transduction efficiencies and expression of l-NGFR on different cell types. Flow cytometric l-NGFR expression analysis was done on viable cells. The M1 region indicates the cell fraction being l-NGFR positive.
Correction of the FA proliferation defect transduced FA cells at 1 and 10 ng/ml MMC whereas the l-NGFR-positive, transduced FAC population shows Applying our novel FAC/l-NGFR vector we took advantage of the flow cytometric multiparameter cell cycle normal cell cycle distribution with no evidence of G2 phase arrest above control sensitivity ( Figure 4b and c, analysis to reveal the cell kinetic of nontransduced and transduced cells by l-NGFR cell surface staining within a upper frames, cell cycle histograms). The quantitative data of FA-specific G2 phase accumusingle assay. The novelty of this type of analysis is shown in Figure 4 . In untreated FAC cells (HSC536) the nonlation in EBV-transformed lymphoblast cell lines derived from FA(C) and FA(D) patients are summarized in Figure  transduced population show background autofluorescence and normal G1/S/G2/M cell cycle distribution 5. As reported previously all Fanconi cell lines tested showed high sensitivity to DNA cross-linking agents (Figure 4a ). The FAC/l-NGFR transduction rate in this assay was 25% and the transduced cells showed an such as MMC, resulting in an increase of the G2 compartment. The flow cytometric cell cycle analysis in HSC536 almost two log increase of ͗l-NGFR͘FITC labeling (X-axis) clearly distinguishing retroviral transduced cells from cells revealed an increase of cells in the G2 phase from 8.7% (control) to 17.8%, 22.5%, 44.3% and 46.6% at 0.1, 1, nontransduced cells. Figure 4a shows that the cell cycle distributions of transduced and nontransduced cells is 10 and 100 ng/ml MMC, respectively. In contrast, HSC536 cells transduced with FAC/l-NGFR vector similar in the non-MMC treated control population. Mitomycin C treatment of the cells induced a G2 arrest after showed no significant increase in G2 phase arrest at FAC relevant concentrations of 1 and 10 ng/ml MMC (8.1% a 24 h incubation period in the presence of 1 and 10 ng/ml MMC (Figure 4b and c, lower frames and cell and 16.2% compared with 22.5% and 44.3%) (Figure 4a ). Even at the highest and already inhibitory concentration cycle histograms).
Within each single assay the physiological heterogenic of 100 ng/ml MMC the G2 accumulation of the transduced cells increased only to 30.4% compared with 44.6% response after MMC treatment of the FA cell population is evident. A significant G2 arrest occurs only in the nonin the nontransduced FAC cells (Figure 4) . In Fanconi Our novel dual laser flow cytometric approach permits fragmented, dead cells originating from transduced and fication of transduction rates due to different survival rates or growth kinetics of transduced and nontransduced cells. Our vector permits more precise estimation of transplanted, viable gene modified cells, which is relevant in clinical settings applying frozen stocks of genetically engineered bone marrow stem cell transplants. Our FAC/l-NGFR vector effectively transduces permanent cell lines of different phylogenetic and ontogenetic origin (E86, NH3T3, K562, B cell lines) showing its general applicability. Since it is evident that purified retroviral vectors instead of complex producer cell line cocultivation systems will be the therapeutic principle for gene therapy we tested transduction protocols with a single retroviral supernatant incubation on normal diploid human cells. 12, 19 In polyclonally activated, normal diploid human cells like lymphocytes (T cells) good primary transduction rates are obtained with a single short-term 2 h infection period. We have also been able to transduce 
cells. Solid line: nontransduced cells. Broken line: transduced cells.
We show for the first time that the l-NGFR expression of all cell types tested was almost identical, independent of phylogenetic or ontogenetic origin of cells. In addition, nontransduced cells was recorded from a l-NGFR/ it was not influenced by factors like growth characterHoechst 33342 dot plot 18 after incubating the cells for 24 istics, medium, serum or long-term expansion. Compared h in the presence of different MMC concentrations. Nonwith other cell surface marker-based vectors the marker transduced FAC HSC536 cells revealed a background gene expression in our cell system was always signifiproportion of 25% of dead cells (control) which increased cantly above background. 20, 21 The l-NGFR expression up to 74% at the highest concentration of 100 ng/ml was similar to that described recently for the gene mark-MMC. The FAC/l-NGFR-transduced cells showed a siging l-NGFR vector in T cells ( LXSN vector ), 17 but significantly lower percentage of 7.5% of cell death even in nificantly higher as described using a N2A murine retrothe untreated control population. The percentage of dead viral backbone. 22 The advantage of high expression is cells remained almost constant over the whole range of evident in cell separation generating pure transplants of tested MMC concentrations (0-100 ng/ml) and increased genetically engineered cells, as well as a diagnostic paraonly to 9.2% at 100 ng/ml MMC ( Figure 6 ). meter giving significant positive/negative discrimination. The effective cell physiological complementation of the Discussion FAC gene in our vector was shown by a decrease of MMC-induced cell cycle defect. Whereas nontransduced In this study we developed a Fanconi group C/l-NGFR retrovirus which enables rapid detection of genetically HSC536 cells show a MMC related increase of G2 phase accumulation, in the transduced HSC536 cells a FA typiengineered cells, quantification of primary transduction rates without selection and functional complementation cal G2 phase accumulation can be detected only at a 100-fold higher MMC concentration. In addition, the rate of of the cellular phenotype of Fanconi anemia. Using flow cytometry the novel l-NGFR cell surface marker is ideally cell death increases only little in transduced cells but significantly in the nontransduced population. Surprisingly, suited for single cell analysis in heterogenous cell populations to reveal cell therapeutic efficiency of retrowe can show for the first time that even the cell death in the control culture (no MMC) was drastically reduced in viruses. 16 Since the l-NGFR expression can be rapidly quantified, we analyzed the primary transduction rates FAC-transduced cells, which is indicative of a survival benefit. The exact role of the FAC gene in the decrease on the K562 model cell system to isolate a stable clone, producing efficiently high-titer amphotropic retroviral of cell death is under further evaluation. Finally, a precondition to achieve a long-term reconstisupernatants. Applying this novel, high-titer FAC retrovirus with a physiological reporter molecule we report tution is to avoid eradication of the transduced bone marrow progenitor and stem cells by the host immune syshere successful functional complementation of the cellular defects of Fanconi anemia complemention group C.
tem. Adenovirus-mediated gene transfer has been shown to cause cellular immunity to viral antigens 23 and in a In addition, this new marker gene provides a rapid and quantitative system to test within a single 48 h experirecent report CD8-positive T cells against the selection marker for hygromycin resistance have been reported in ment whether Fanconi cells of patients with an unknown complementation group belong to group C.
HIV patients. 14 In our system neither viral nor bacterial proteins are expressed leading to MHC class I presenIn the Fanconi relevant hematopoietic CD34 cells we are able to determine directly the transduced progenitor tation of foreign peptides which might potentially be recognized by the immune system. Since soluble l-NGFR cells which express l-NGFR and CD34 markers, which is not feasible with G418 selection or colony PCR. 12 Since receptors have been found in the urine 14 and since they are expressed on cells in vivo it is unlikely that an selection markers like neomycin or hygromycin require selection steps over several days or weeks, 12, 14 an immune reaction occurs against retroviral FAC/l-NGFRtransduced bone marrow progenitor/stem cells. extended selection period might result in a bias of quanti- marrow/cord blood progenitor/stem cells and provides the possibility of a rapid analysis of transduced cells even PBLs were incubated for 2 h in 5 ml cell-free 0.22 m filtered viral supernatant at 37°C. After infection cells within a heterogenous cell population in a single assay. Our FAC/l-NGFR vector fully complements the proliferwere pelleted and resuspended in medium as described above. ative cell cycle G2 phase defect in FAC cells. We expect that this novel gene therapy vector type will be further used as a reporter and cell separation tool applying other Infection of human CD34 + cells Cord blood PBMCs were separated by Ficoll gradient Fanconi genes from different complementation groups or DNA repair genes. 8 In addition to the complementation centrifugation and frozen in IMDM (GIBCO) supplemented with 10% DMSO, 10% FCS. After thawing and of the monogenetic defective gene, partial correction and survival benefit might also be investigated using other incubation overnight in IMDM (GIBCO), Penstrep (Boehringer Mannheim), 20% human plasma the genes dysregulated downstream of the FA gene in the complex network of the cell cycle. Dickinson) and 100 mW 488 nm excitation.
Retroviral vectors
Cell cycle analysis of transduced B cell lines The basic l-NGFR vector was obtained from C Bordignon Cell cycle analysis of viable cells was performed by dual (Milan). The FAC gene was cloned downstream of a SV40 laser flow cytometry. The FA B cells were plated at promotor and the vector was converted to corresponding 1 × 10 5 /ml and grown overnight. MMC was added at virus by lipofection with Lipofectamine (GIBCO) into the concentrations indicated and cells were incubated for E86 cell line according to the manufacturer's manual. The 24 h. 1 × 10 6 Cells were pelleted and l-NGFR expressing transduced E86 cells were cloned with a FACStar plus cells were immunostained as described above. Subcell sorter (Becton Dickinson, Mountain View, CA, USA) sequent to l-NGFR labelling the cells were incubated in using the expression of l-NGFR. Optimal viral superthe presence of 8 g/ml Hoechst 33342 for 30 min at 37°C natants of E86 cell lines were used to transform the and kept on ice until flow cytometry analysis. To identify amphotropic producer cell line. The producer cell line dead cells 1 g/ml propidium iodide (PI) was added. was again cloned by FACS using l-NGFR cell surface Cell cycles of l-NGFR expressing cells and l-NGFR-negaexpression. Supernatants from retrovirus producing tive cells were analyzed on a FACStar plus flow cytoclones showing the highest transduction rates on K562 meter (Becton Dickinson). The dual laser excitation was cells were selected and used in further experiments.
at 50 mW of 352/365 nm for Hoechst 33342 (cell cycle) and PI (dead cells), and at 100 mW of 488 nm for FITC Infection of FA B cell lines (l-NGFR). Viable and dead cells were gated in a PI versus 1 × 10 6 Target cells were infected for 2 h with 50% (v/v) FSC plot. Hoechst 33342 fluorescence was used in a peak 0.22 m filtered viral supernatants and 50% standard cell versus area plot to gate out cell debris and clumps from culture medium. Analysis by flow cytometry was perforliving cells. med after a culture period of 16-48 h.
